Healthcare provider profile · identity verified

Jon D. Casimir, MD

Family Practice · MCPHERSON, KS · NPI 1376572818

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Rosuvastatin Calcium	Rosuvastatin Calcium	607	68
Gabapentin	Gabapentin	325	34
Omeprazole	Omeprazole	314	34
Potassium Chloride	Potassium Chloride	304	40
Pantoprazole Sodium	Pantoprazole Sodium	282	34
Levothyroxine Sodium	Levothyroxine Sodium	274	28
Metoprolol Tartrate	Metoprolol Tartrate	260	31
Amlodipine Besylate	Amlodipine Besylate	257	28
Furosemide	Furosemide	243	33
Lisinopril	Lisinopril	214	27
Losartan Potassium	Losartan Potassium	210	25
Xarelto	Rivaroxaban	181	20
Sertraline Hcl	Sertraline Hcl	177	20
Trazodone Hcl	Trazodone Hcl	162	18
Allopurinol	Allopurinol	144	13
Metformin Hcl	Metformin Hcl	141	14
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	138	20
Clopidogrel	Clopidogrel Bisulfate	126	13
Duloxetine Hcl	Duloxetine Hcl	121	16
Buspirone Hcl	Buspirone Hcl	115	12
Montelukast Sodium	Montelukast Sodium	108	suppressed
Metoprolol Succinate	Metoprolol Succinate	106	suppressed
Carvedilol	Carvedilol	105	suppressed
Mirtazapine	Mirtazapine	101	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	93	suppressed
Eliquis	Apixaban	89	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	88	20
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	87	suppressed
Ropinirole Hcl	Ropinirole Hcl	80	suppressed
Bupropion Xl	Bupropion Hcl	74	suppressed
Trulicity	Dulaglutide	73	12
Donepezil Hcl	Donepezil Hcl	70	suppressed
Spironolactone	Spironolactone	68	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	67	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	66	31
Levetiracetam	Levetiracetam	64	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	64	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	63	suppressed
Clonazepam	Clonazepam	62	suppressed
Meloxicam	Meloxicam	62	13
Tamsulosin Hcl	Tamsulosin Hcl	61	suppressed
Fluticasone Propionate	Fluticasone Propionate	60	19
Amiodarone Hcl	Amiodarone Hcl	58	suppressed
Lamotrigine	Lamotrigine	58	suppressed
Tramadol Hcl	Tramadol Hcl	58	20
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	52	suppressed
Citalopram Hbr	Citalopram Hydrobromide	51	suppressed
Ozempic	Semaglutide	50	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	50	suppressed
Atenolol	Atenolol	45	suppressed
Prednisone	Prednisone	44	suppressed
Pregabalin	Pregabalin	42	suppressed
Alendronate Sodium	Alendronate Sodium	41	suppressed
Estradiol	Estradiol	40	suppressed
Famotidine	Famotidine	39	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	38	suppressed
Topiramate	Topiramate	38	suppressed
Glipizide	Glipizide	37	suppressed
Januvia	Sitagliptin Phosphate	37	suppressed
Primidone	Primidone	36	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	35	suppressed
Methylprednisolone	Methylprednisolone	35	25
Nortriptyline Hcl	Nortriptyline Hcl	34	suppressed
Atorvastatin Calcium	Atorvastatin Calcium	33	suppressed
Bumetanide	Bumetanide	33	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	33	21
Midodrine Hcl	Midodrine Hcl	33	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	32	suppressed
Finasteride	Finasteride	32	suppressed
Jardiance	Empagliflozin	32	suppressed
Lorazepam	Lorazepam	31	suppressed
Metformin Hcl Er	Metformin Hcl	31	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	30	suppressed
Solifenacin Succinate	Solifenacin Succinate	30	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	29	suppressed
Linzess	Linaclotide	29	suppressed
Memantine Hcl	Memantine Hcl	29	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	28	21
Loperamide	Loperamide Hcl	28	suppressed
Chlorthalidone	Chlorthalidone	27	suppressed
Ondansetron Odt	Ondansetron	27	11
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	27	suppressed
Vilazodone Hcl	Vilazodone Hcl	27	suppressed
Olanzapine	Olanzapine	26	suppressed
Ondansetron Hcl	Ondansetron Hcl	26	suppressed
Propranolol Hcl Er	Propranolol Hcl	26	suppressed
Benztropine Mesylate	Benztropine Mesylate	25	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	25	suppressed
Nitroglycerin	Nitroglycerin	25	13
Nyamyc	Nystatin	25	11
Digoxin	Digoxin	24	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	24	suppressed
Divalproex Sodium	Divalproex Sodium	23	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	23	suppressed
Colestipol Hcl	Colestipol Hcl	22	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	22	suppressed
Asenapine Maleate	Asenapine Maleate	21	suppressed
Baclofen	Baclofen	21	suppressed
Paroxetine Hcl	Paroxetine Hcl	21	suppressed
Rivastigmine	Rivastigmine Tartrate	21	suppressed
Carbamazepine Er	Carbamazepine	20	suppressed
Prazosin Hcl	Prazosin Hcl	20	suppressed
Hydralazine Hcl	Hydralazine Hcl	19	suppressed
Propranolol Hcl	Propranolol Hcl	19	suppressed
Spiriva Respimat	Tiotropium Bromide	19	suppressed
Synthroid	Levothyroxine Sodium	19	suppressed
Ursodiol	Ursodiol	19	suppressed
Cephalexin	Cephalexin	18	suppressed
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	18	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	18	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	18	suppressed
Brilinta	Ticagrelor	17	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	17	suppressed
Risperidone	Risperidone	17	suppressed
Bethanechol Chloride	Bethanechol Chloride	16	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	16	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	16	suppressed
Bupropion Hcl Sr	Bupropion Hcl	15	suppressed
Ezetimibe	Ezetimibe	15	suppressed
Gemtesa	Vibegron	15	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	15	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	15	suppressed
Quetiapine Fumarate Er	Quetiapine Fumarate	15	suppressed
Valacyclovir	Valacyclovir Hcl	15	suppressed
Warfarin Sodium	Warfarin Sodium	15	suppressed
Abrysvo	Rsv Vacc, Pref A And Pref B/Pf	14	14
Clonidine Hcl	Clonidine Hcl	14	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	14	suppressed
Sucralfate	Sucralfate	14	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	13	suppressed
Alogliptin-Metformin	Alogliptin Benz/Metformin Hcl	13	suppressed
Calcitriol	Calcitriol	13	suppressed
Ceftriaxone	Ceftriaxone Sodium	13	13
Cimetidine	Cimetidine	13	suppressed
Diclofenac Sodium	Diclofenac Sodium	13	suppressed
Estradiol (Once Weekly)	Estradiol	13	suppressed
Fluticasone Propionate Hfa	Fluticasone Propionate	13	suppressed
Fluvoxamine Maleate	Fluvoxamine Maleate	13	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	13	suppressed
Mounjaro	Tirzepatide	13	suppressed
Olanzapine-Fluoxetine Hcl	Olanzapine/Fluoxetine Hcl	13	suppressed
Ranolazine Er	Ranolazine	13	suppressed
Sotalol	Sotalol Hcl	13	suppressed
Verapamil Hcl	Verapamil Hcl	13	suppressed
Xigduo Xr	Dapaglifloz Propaned/Metformin	13	suppressed
Aimovig Autoinjector	Erenumab-Aooe	12	suppressed
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	12	suppressed
Nabumetone	Nabumetone	12	suppressed
Tiotropium Bromide	Tiotropium Bromide	12	suppressed
Vancomycin Hcl	Vancomycin Hcl	12	suppressed
Flecainide Acetate	Flecainide Acetate	11	suppressed
Isosorbide Mononitrate	Isosorbide Mononitrate	11	suppressed
Leflunomide	Leflunomide	11	suppressed
Timolol Maleate	Timolol Maleate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error